3rd Quarter - Report — LMH STRATEGIC SOLUTIONS for REGENXBIO INC. (2025)

Firm

LMH STRATEGIC SOLUTIONS

Client

REGENXBIO INC.

Income

$60,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Prescription drug payment reform. Pharmaceutical supply chain.

Lobbyist	Covered position, as disclosed
ALANNA TEMME	Legislative Director, U.S. Representative Jon Porter

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

General Medicare and Medicaid Issues.

Lobbyist	Covered position, as disclosed
ALANNA TEMME	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.